Jennison Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01B | Buy |
|
|||||
|
2025
Q1 | $719M | Buy |
|
|||||
|
2024
Q4 | $594M | Buy |
|
|||||
|
2024
Q3 | $465M | Buy |
|
|||||
|
2024
Q2 | $44.1M | Buy |
|
|||||
|
2024
Q1 | $53.9M | Buy |
|
|||||
|
2023
Q4 | $46.9M | Sell |
|
|||||
|
2023
Q3 | $400M | Sell |
|
|||||
|
2023
Q2 | $936M | Buy |
|
|||||
|
2023
Q1 | $844M | Sell |
|
|||||
|
2022
Q4 | $1.04B | Buy |
|
|||||
|
2022
Q3 | $559M | Sell |
|
|||||
|
2022
Q2 | $638M | Sell |
|
|||||
|
2022
Q1 | $1.33B | Buy |
|
|||||
|
2021
Q4 | $761M | Sell |
|
|||||
|
2021
Q3 | $844M | Sell |
|
|||||
|
2021
Q2 | $682M | Sell |
|
|||||
|
2021
Q1 | $611M | Sell |
|
|||||
|
2020
Q4 | $736M | Sell |
|
|||||
|
2020
Q3 | $1.13B | Sell |
|
|||||
|
2020
Q2 | $1.12B | Buy |
|
|||||
|
2020
Q1 | $725M | Sell |
|
|||||
|
2019
Q4 | $757M | Sell |
|
|||||
|
2019
Q3 | $603M | Buy |
|
|||||
|
2019
Q2 | $209M | Buy |
|
|||||
|
2019
Q1 | $53.3M | Buy |
|
|||||
|
2018
Q4 | $52M | Sell |
|
|||||
|
2018
Q3 | $74.4M | Sell |
|
|||||
|
2018
Q2 | $59.3M | Sell |
|
|||||
|
2018
Q1 | $72.5M | Sell |
|
|||||
|
2017
Q4 | $73.4M | Sell |
|
|||||
|
2017
Q3 | $82.3M | Sell |
|
|||||
|
2017
Q2 | $130M | Buy |
|
|||||
|
2017
Q1 | $127M | Buy |
|
|||||
|
2016
Q4 | $87.5M | Buy |
|
|||||
|
2016
Q3 | $105M | Sell |
|
|||||
|
2016
Q2 | $136M | Buy |
|
|||||
|
2016
Q1 | $106M | Buy |
|
|||||
|
2015
Q4 | $96M | Buy |
|
|||||
|
2015
Q3 | $82.8M | Buy |
|
|||||
|
2015
Q2 | $27.3M | Buy |
|
|||||
|
2015
Q1 | $2.56M | Sell |
|
|||||
|
2014
Q4 | $3.38M | Sell |
|
|||||
|
2014
Q3 | $2.75M | Sell |
|
|||||
|
2014
Q2 | $2.8M | Buy |
|
|||||
|
2014
Q1 | $1.97M | Sell |
|
|||||
|
2013
Q4 | $3.25M | Sell |
|
|||||
|
2013
Q3 | $2.99M | Buy |
|
|||||
|
2013
Q2 | $1.86M | Buy |
|